Nationwide Fund Advisors - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 125 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$89,000
-71.5%
71,907
-29.0%
0.00%
-100.0%
Q1 2017$312,000
-32.0%
101,307
-9.9%
0.00%
-50.0%
Q4 2016$459,000
-38.0%
112,384
-3.5%
0.00%
-33.3%
Q3 2016$740,000
+13.8%
116,513
-3.3%
0.00%0.0%
Q2 2016$650,000
-16.9%
120,513
+29.0%
0.00%0.0%
Q1 2016$782,000
+6.5%
93,415
+0.5%
0.00%0.0%
Q4 2015$734,000
+21.1%
92,962
+30.5%
0.00%0.0%
Q3 2015$606,000
-31.2%
71,2330.0%0.00%
-25.0%
Q2 2015$881,000
+3.2%
71,233
-0.9%
0.00%
+33.3%
Q1 2015$854,000
+1.1%
71,857
-3.9%
0.00%
-25.0%
Q4 2014$845,000
+27.6%
74,738
-0.9%
0.00%
+33.3%
Q3 2014$662,000
+19.9%
75,430
-0.4%
0.00%
+50.0%
Q2 2014$552,000
+46.4%
75,766
+1.4%
0.00%0.0%
Q1 2014$377,000
-5.5%
74,715
+0.0%
0.00%0.0%
Q4 2013$399,000
+37.1%
74,712
-2.5%
0.00%
+100.0%
Q3 2013$291,000
+20.2%
76,634
+113.5%
0.00%0.0%
Q2 2013$242,00035,8870.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders